Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/23/2014 07/24/2014 07/25/2014 07/28/2014 07/29/2014 Date
5.88(c) 6.183(c) 5.89(c) 5.61(c) 6.17 Last
25 419 798 26 751 710 10 835 423 7 517 208 16 634 210 Volume
+15.29% +5.15% -4.74% -4.75% +9.98% Change
More quotes
Company
ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113. Its approach to structure-based drug... 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
Surperformance© rating of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More about the company
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 82,6 M
EBIT 2014 -197 M
Net income 2014 -195 M
Finance 2014 169 M
Yield 2014 -
Sales 2015 162 M
EBIT 2015 -131 M
Net income 2015 -126 M
Finance 2015 142 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 10,6x
EV / Sales 2015 5,60x
Capitalization 1 048 M
More Financials
Latest news on ARIAD PHARMACEUTICALS, INC
6d ago ARIAD PHARMACEUTICALS : Announces Continuation of Iclusig Review under the Artic..
07/18 ARIAD PHARMACEUTICALS : Assigned Patent
07/17 ARIAD PHARMACEUTICALS : Thursday's ETF Movers: GDXJ, XBI
07/16 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Second Quarter 2014 Financ..
07/14 ARIAD PHARMACEUTICALS : Announces Continuation of Iclusig Review under the Artic..
07/02 ARIAD PHARMACEUTICALS : Researchers Submit Patent Application, "Methods and Comp..
06/28 ARIAD PHARMACEUTICALS : Bolsters Its Global Management Team with 3 Recent Appoin..
06/26 ARIAD PHARMACEUTICALS : Change in Directors or Principal Officers, Submission of..
06/26 ARIAD PHARMACEUTICALS : Strengthens Its Global Management Team with 3 Recent App..
06/24 ARIAD PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial St..
06/23 ARIAD PHARMACEUTICALS : Announces Three Key Appointments to Its Global Managemen..
06/22 ARIAD PHARMACEUTICALS : Proposes $175 Million Offering of Convertible Senior Not..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
Ariad Pharmaceuticals, Inc : Income Statement Evolution
More Financials
EPS Revisions
Ariad Pharmaceuticals, Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF